Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution
Revista Brasileira de Epidemiologia · 2023
DOI: 10.1590/1980-549720230045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Brasileira de Epidemiologia, 2023. Verfasst von Débora Silva Gonçalves und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Cardiologia, Professional Master's Program in Health Technology Assessment - Rio de Janeiro (RJ), Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To characterize associated factors and overall survival of women with metastatic breast cancer treated with trastuzumab after its incorporation into the SUS, and additionally to present the direct costs of this technology.
Methods
This is a retrospective cohort, based on data from computerized medical records from one of the units of the National Cancer Institute (INCA), in Rio de Janeiro-RJ, Brazil. Women with HER-2 positive metastatic breast cancer undergoing trastuzumab treatment from September 2017 to August 2018 were included. Overall survival was estimated using the Kaplan-Meier method and compared between groups using the log-rank test.
Results
136 women were selected, whose median age at diagnosis was 51 years (range: 21–81 years). The median OS was 43.63 months (95%CI 33.92–53.34). It is observed that the median OS for the population already diagnosed with metastatic disease (stage IV) was significantly lower than for patients diagnosed in stages I-III (37.43 months vs. 48.6 months, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto Nacional de Cardiologia, Professional Master's Program in Health Technology Assessment - Rio de Janeiro (RJ), Brazil.
- Instituto Nacional do Câncer José Alencar Gomes da Silva - Rio de Janeiro (RJ), Brazil.
- Universidade de Brasília, School of Health Sciences, Department of Collective Health - Brasília (DF), Brazil.
ORCID-Profile: Débora Silva Gonçalves, Arn Migowski, Susanne Crocamo Ventilari da Costa, Rodrigo Saar da Costa, Katia Marie Simões E Senna, Ivan Ricardo Zimmermann
Zitieren
APA
Gonçalves, D. S., Migowski, A., Costa, S. C. V. D., Costa, R. S. D., Senna, K. M. S. E., & Zimmermann, I. R. (2023). Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution. Revista Brasileira de Epidemiologia. https://doi.org/10.1590/1980-549720230045
Vancouver
Gonçalves DS, Migowski A, Costa SCVD, Costa RSD, Senna KMSE, Zimmermann IR. Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution. Revista Brasileira de Epidemiologia. 2023. doi:10.1590/1980-549720230045
BibTeX
@article{Gonalves2023,
author = {Gonçalves, Débora Silva and Migowski, Arn and Costa, Susanne Crocamo Ventilari da and Costa, Rodrigo Saar da and Senna, Katia Marie Simões E and Zimmermann, Ivan Ricardo},
title = {Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution},
journal = {Revista Brasileira de Epidemiologia},
year = {2023},
doi = {10.1590/1980-549720230045}
}
EUVIMED